初治人类免疫缺陷病毒感染者合并代谢综合征及心血管病风险状况及其临床特点分析

doi:10.3969/j.issn.1006-7795.2020.01.008

首都医科大学学报 ›› 2020, Vol. 41 ›› Issue (1): 40-44.doi: 10.3969/j.issn.1006-7795.2020.01.008

• 糖尿病的临床与基础研究 • 上一篇下一篇

初治人类免疫缺陷病毒感染者合并代谢综合征及心血管病风险状况及其临床特点分析

王延雪¹, 胡虹英¹, 李新刚¹, 鹿星梦¹, 郜桂菊², 梁洪远², 肖江², 杨涤², 王芳², 韩晓涛³

1. 首都医科大学附属北京地坛医院内分泌科, 北京 100015;
2. 首都医科大学附属北京地坛医院感染一科, 北京 100015;
3. 首都医科大学附属北京地坛医院心内科, 北京 100015

收稿日期:2019-12-12 出版日期:2020-02-21 发布日期:2020-02-13
通讯作者: 郜桂菊 E-mail:guiju.gao@163.com
基金资助:
“十三五”艾滋病和病毒性肝炎等重大传染病防治科技重大专项（2017ZX10202101004）。

A study of metabolic syndrome and cardiovascular disease risk status in highly active antiretroviral therapy-naive patients with human immunodeficiency virus infection

Wang Yanxue¹, Hu Hongying¹, Li Xingang¹, Lu Xingmeng¹, Gao Guiju², Liang Hongyuan², Xiao Jiang², Yang Di², Wang Fang², Han Xiaotao³

1. Department of Endocrinology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;
2. Division;
1 of Infection Disease, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;
3. Department of Cardiology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China

Received:2019-12-12 Online:2020-02-21 Published:2020-02-13
Supported by:
This study was supported by Study on Non-AIDS Related Disease Control Strategies in Patients with Long-term Antiviral Therapy, the Program for the 13th Five-year Plan of China (2017ZX10202101004).

摘要/Abstract

摘要： 目的探讨尚未进行高效抗反转录病毒治疗（highly active antiretroviral therapy，HAART）的人类免疫缺陷病毒（human immunodeficiency virus，HIV）感染者代谢综合征（metabolic syndrome，MS）及心血管病风险状况及其临床特点。方法以HIV感染者193人为研究对象，按照MS的诊断标准选择诊断为MS的患者为MS组，选对应的非MS患者为非MS组；按照Framingham风险评分筛选心血管病中高危患者为中高危组，低危者为低危组。分别比较2组的临床特征。结果本研究中代谢综合征的患病率为9.33%，MS各组分中比例最大的为体质量指数（body mass index，BMI）≥25 kg/m²，其次为高密度脂蛋白胆固醇降低。与对照组相比，代谢综合征患者年龄更高，BMI较大，差异有统计学意义（P < 0.05）；MS患者的心血管病风险明显高于非MS患者，年龄、BMI和吸烟史与初治HIV感染者心血管病风险有关，冠状动脉粥样硬化性心脏病风险评估为中高危组患者HIV RNA载量更高，但差异无统计学意义。结论年龄与BMI与初治HIV感染者代谢综合征风险有关，MS患者心血管病风险明显高于非MS者。HAART治疗前需评估相关危险因素，密切监测并控制患者代谢紊乱及心血管疾病。

关键词: 人类免疫缺陷病毒, 初治, 代谢综合征, 心血管风险

Abstract: Objective To investigate the clinical characteristics as well of metabolic syndrome(MS) and risk status of cardiovascular disease in highly active antiretroviral therapy(HAART)-naive patients with human immunodeficiency virus(HIV) infection.Methods With 193 HIV infected patients as the study subjects, patients with(case group)and without(control group)MS were identified according to the MS diagnostic criteria, According to the Framingham risk score, patients with high risk of cardiovascular disease were selected as middle and high risk group, and those with low risk were selected as low risk group. Clinical characteristics were analysed by comparing the two groups. Results In our research, the prevalence of MS was 9.33%. The largest component was body mass index (BMI) ≥ 25 kg/m², followed by a decrease in high density lipoprotein cholesterol(HDL-C).Compared with the control group, patients with MS were older, and they had larger body mass index (BMI) (P < 0.05). The cardiovascular risk of MS patients was significantly higher than those without MS.Age, BMI and smoking history were associated with cardiovascular risk in newly diagnosed HIV patients. Patients at high risk of coronary heart disease had higher HIV RNA load, but the difference was not statistically significant.Conclusion Age and BMI were associated with the risk of metabolic syndrome.Cardiovascular risk of MS patients was significantly higher than those without MS.Related risk factors should be evaluated before HAART, and metabolic disorders and cardiovascular diseases should be closely monitored.

Key words: human immunodeficiency virus, highly active antiretroviral therapy-naive, metabolic syndrome, cardiovascular disease risk

中图分类号:

R589

王延雪, 胡虹英, 李新刚, 鹿星梦, 郜桂菊, 梁洪远, 肖江, 杨涤, 王芳, 韩晓涛. 初治人类免疫缺陷病毒感染者合并代谢综合征及心血管病风险状况及其临床特点分析[J]. 首都医科大学学报, 2020, 41(1): 40-44.

Wang Yanxue, Hu Hongying, Li Xingang, Lu Xingmeng, Gao Guiju, Liang Hongyuan, Xiao Jiang, Yang Di, Wang Fang, Han Xiaotao. A study of metabolic syndrome and cardiovascular disease risk status in highly active antiretroviral therapy-naive patients with human immunodeficiency virus infection[J]. Journal of Capital Medical University, 2020, 41(1): 40-44.

参考文献

[1] Kibirige D, Ssekitoleko R. Endocrine and metabolic abnormalities among HIV-infected patients:a current review[J]. Int J STD AIDS,2013, 24(8):603-611.
[2] 中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2004,12(3):156-161.
[3] 郭海健,念馨,梁友芳,等.基于多中心横断面调查的中国人群代谢综合征的流行情况及危险因素[J].中华疾病控制杂志, 2019,23(7):796-801.
[4] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防与控制中心.中国艾滋病诊疗指南(2018版)[J].新发传染病电子杂志, 2019,4(2):65-84.
[5] Pearson T A, Blair S N, Daniels S R, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke:2002 update:consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee[J]. Circulation, 2002, 106(3):388-391.
[6] Quiros-Roldan E, Raffetti E, Focà E, et al. Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade:a population-based study from 2000 to 2012[J]. AIDS Care, 2016, 28(12):1551-1558.
[7] Wand H, Calmy A, Carey D L, et al. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection[J]. AIDS, 2007, 21(18):2445-2453.
[8] Nix L M, Tien P C. Metabolic syndrome, diabetes, and cardiovascular risk in HIV[J]. Curr HIV/AIDS Rep, 2014, 11(3):271-278.
[9] Raposo M A, Armiliato G N A, Guimaraães N S, et al. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy[J]. Rev Soc Bras Med Trop, 2017, 50(5):598-606.
[10] Muhammad F Y, Gezawa I D, Uloko A,et al. Metabolic syndrome among HIV infected patients:a comparative cross sectional study in northwestern Nigeria[J]. Diabetes Metab Syndr, 2017, 11 Suppl 1:S523-S529.
[11] Shen Y, Wang Z, Liu L, et al. Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China[J]. BMC Infect Dis, 2013,13:79.
[12] Wu P Y, Hung C C, Liu W C, et al. Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy:prevalence and associated factors[J]. J Antimicrob Chemother, 2012, 67(4):1001-1009.
[13] Bonfanti P, De Socio G V, Ricci E, et al. The feature of metabolic syndrome in HIV naive patients is not the same of those treated:results from a prospective study[J]. Biomed Pharmacother, 2012, 66(5):348-353.
[14] Feinstein M J, Hsue P Y, Benjamin L A, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV:a scientific statement from the American Heart Association[J]. Circulation,2019, 140(2):e98-e124.
[15] Guo F, Hsieh E, Lv W, et al. Cardiovascular disease risk among Chinese antiretroviral-naive adults with advanced HIV disease[J]. BMC Infect Dis, 2017, 17(1):287.

初治人类免疫缺陷病毒感染者合并代谢综合征及心血管病风险状况及其临床特点分析

A study of metabolic syndrome and cardiovascular disease risk status in highly active antiretroviral therapy-naive patients with human immunodeficiency virus infection

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	苏志燕, 刘薇, 史婷婷. 老年2型糖尿病患者血尿酸浓度与代谢综合征的相关性分析[J]. 首都医科大学学报, 2023, 44(1): 137-142.
[2]	刘真, 殷冬梅, 战思恩, 阮祥燕. 黄连素改善多囊卵巢综合征患者代谢异常的系统评价[J]. 首都医科大学学报, 2021, 42(4): 588-595.
[3]	来璇, 张爱华. 代谢综合征对慢性肾脏病患者生存预后的影响[J]. 首都医科大学学报, 2021, 42(4): 609-614.
[4]	闵敏, 阮祥燕, 王虎生, 程姣姣, 罗穗豫, 许仲婷, 李萌, Alfred O. Mueck. 奥利司他综合干预对超重或肥胖型多囊卵巢综合征患者代谢综合征及其组分的影响[J]. 首都医科大学学报, 2020, 41(4): 514-519.
[5]	修双玲, 穆志静, 孙丽娜, 赵蕾, 韩青, 曹雪霞. 老年2型糖尿病代谢综合征患者骨质疏松危险因素研究[J]. 首都医科大学学报, 2020, 41(1): 108-112.
[6]	庄文旭, 张伟波, 朱有为, 朱益, 蔡军. 对精神分裂症躯体健康问题的生活方式干预[J]. 首都医科大学学报, 2019, 40(5): 698-702.
[7]	王凯丽, 陈世璋. 人类免疫缺陷病毒感染者拔牙围手术期的风险评估和管理[J]. 首都医科大学学报, 2019, 40(5): 754-757.
[8]	宋冰冰, 陆小凡, 翁文佳, 粟斌, 张彤, 高艳青. HIV-1慢性感染者外周血中CD8⁺干细胞样记忆型T细胞变化以及对疾病进展的影响[J]. 首都医科大学学报, 2017, 38(5): 650-653.
[9]	张鲲, 张婵媛, 陈剑, 鲁炳怀. 老年代谢综合征人群胱抑素C浓度研究[J]. 首都医科大学学报, 2017, 38(4): 535-540.
[10]	李海彬, 陶丽新, 郭晋, 刘相佟, 杨昆, 曹凯, 王超, 闫焱, 郭秀花. 北京市某三级医院体检人群尿酸与代谢综合征关联性研究[J]. 首都医科大学学报, 2016, 37(5): 631-635.
[11]	李扬璐, 阮祥燕, 赵越, 杜娟, 王利娟, 崔亚美, Alfred O. Mueck. 达英-35对多囊卵巢综合征患者糖脂代谢的影响[J]. 首都医科大学学报, 2016, 37(4): 424-430.
[12]	詹艺, 施裕新. MRI诊断评估HIV相关认知功能障碍的研究进展[J]. 首都医科大学学报, 2016, 37(4): 481-485.
[13]	刘相佟, 陶丽新, 杨昆, 李海彬, 郭晋, 郭秀花. 血红蛋白与成人代谢综合征及其组分关联性的五年队列研究[J]. 首都医科大学学报, 2016, 37(4): 509-512.
[14]	杨昆, 陶丽新, 曹凯, 刘相佟, 李海彬, 闫傲霜, 郭秀花. 代谢综合征与相应血常规指标的关联性研究[J]. 首都医科大学学报, 2016, 37(2): 203-207.
[15]	田飞, 王媛媛, 马韻芳, 汪静, 孔令坤. 北京市东城区两种男男性行为人群干预模式的干预效果评价[J]. 首都医科大学学报, 2016, 37(2): 233-237.